Table 2. Drugs for rate control.
Drug | Route | Typical dose | Contra-indications | References |
â-blockers | ||||
Metoprolol (tartrate) | Oral | 25–100 mg, BID | Acute pulmonary oedema, heart failure, asthma, severe atrioventricular block and severely depressed patients | 17, 28 |
Metoprolol (succinate) | Oral | 50–400 mg, QD | ||
Bisoprolol | Oral | 2.5–10 mg, QD | ||
Atenolol | Oral | 25–100 mg, QD | ||
ND-CCBs | ||||
Diltiazem | Oral | 120–360 mg QD | Severe hypotension, cardiogenic shock, second- or third-degree atrioventricular block or sick sinus syndrome without a pacemaker, patients with left ventricular systolic dysfunction and decompensated heart failure owing to their negative inotropic effects | 17, 21, 28 |
IV | 0.25 mg/kg IV bolus over 2 min, then 5–15 mg/h | |||
Verapamil | Oral | 120–480 mg QD | ||
IV | (0.075–0.15 mg/kg) IV bolus over 2 min, then 0.005 mg/kg/min infusion | |||
Digitalis glycosides | ||||
Digoxin | Oral | 0.125–0.25 mg QD | Ventricular tachycardia, hypertrophic obstructive cardiomyopathy | 17, 21, 28 |
IV | 0.25 mg IV with repeat dosing to a maximum of 1.5 mg over 24 h | |||
Specific indications | ||||
Amiodarone | Oral | 100–200 mg QD | Severe sinus node dysfunction, second- or third-degree atrioventricular block or bundle branch disease, syncope caused by bradycardia | 21, 28 |
IV | 300 mg IV over 1 h, then 10–50 mg/h over 24 h |
QD, once daily; BID, twice daily; IV, intravenous.